Younger Adults, Women with Cancer Respond Less Well to Immunotherapy with Checkpoint Inhibitors
September 16th 2020, 1:00pm
ArticleYounger and female patients with a variety of cancer types tend to have strong immune systems that naturally fight an array of cancer cells. The tumor cells the immune system doesn’t destroy are the most evasive, both to the immune system and medications that boost its activity, and this makes checkpoint inhibitor immunotherapy less effective in this population.
